Related Experiment Video
Updated: May 17, 2026
Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover
Published on: May 23, 2016
Challenges measuring cardiomyocyte renewal
Mark H Soonpaa1, Michael Rubart, Loren J Field
1Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Abstract:
Interventions to effect therapeutic cardiomyocyte renewal have received considerable interest of late. Such interventions, if successful, could give rise to myocardial regeneration in diseased hearts. Regenerative interventions fall into two broad categories, namely approaches based on promoting renewal of pre-existing cardiomyocytes and approaches based on cardiomyogenic stem cell activity. The latter category can be further subdivided into approaches promoting differentiation of endogenous cardiomyogenic stem cells, approaches wherein cardiomyogenic stem cells are harvested, amplified or enriched ex vivo, and subsequently engrafted into the heart, and approaches wherein an exogenous stem cell is induced to differentiate in vitro, and the resulting cardiomyocytes are engrafted into the heart. There is disagreement in the literature regarding the degree to which cardiomyocyte renewal occurs in the normal and injured heart, the mechanism(s) by which this occurs, and the degree to which therapeutic interventions can enhance regenerative growth. This review discusses several caveats which are encountered when attempting to measure cardiomyocyte renewal in vivo which likely contribute, at least in part, to the disagreement regarding the levels at which this occurs in normal, injured and treated hearts. This article is part of a Special Issue entitled: Cardiomyocyte biology: Cardiac pathways of differentiation, metabolism and contraction.
Insights
Therapeutic cardiomyocyte renewal aims for myocardial regeneration in diseased hearts. This review explores methods and challenges in measuring cardiomyocyte renewal for effective cardiac repair strategies.
Area of Science:
- Cardiovascular Biology
- Regenerative Medicine
- Stem Cell Therapy
Background:
- Therapeutic cardiomyocyte renewal is a key area of interest for myocardial regeneration in diseased hearts.
- Regenerative strategies include promoting existing cardiomyocyte renewal or utilizing cardiomyogenic stem cell activity.
- Stem cell approaches involve endogenous stem cell differentiation, ex vivo manipulation, or in vitro differentiation of exogenous stem cells.
Purpose of the Study:
- To review interventions for therapeutic cardiomyocyte renewal and myocardial regeneration.
- To discuss the challenges and disagreements in measuring cardiomyocyte renewal in normal, injured, and treated hearts.
- To highlight caveats in in vivo measurement techniques that contribute to literature discrepancies.
Main Methods:
- Review of existing literature on cardiomyocyte renewal and myocardial regeneration.
- Analysis of different categories of regenerative interventions.
- Discussion of methodological challenges in assessing cardiomyocyte renewal in vivo.
Main Results:
- Two broad categories of regenerative interventions exist: promoting pre-existing cardiomyocyte renewal and cardiomyogenic stem cell activity.
- Stem cell approaches have further subdivisions based on endogenous or exogenous cell sources and manipulation methods.
- Significant disagreement persists regarding the extent and mechanisms of cardiomyocyte renewal and the efficacy of therapeutic interventions.
Conclusions:
- Measuring cardiomyocyte renewal in vivo presents significant caveats that contribute to ongoing scientific debate.
- Understanding these measurement challenges is crucial for advancing myocardial regeneration therapies.
- Further research is needed to standardize methods and resolve discrepancies in cardiomyocyte renewal studies.
